نتایج جستجو برای: drug resistant tumors

تعداد نتایج: 896695  

Journal: :Cancer research 1983
R Ganapathi D Grabowski

Resistance to the cytotoxic effects of daunomycin and Adriamycin (ADR) in sublines of Ehrlich ascites and P388 mouse tumors has been demonstrated to be due to reduced cellular accumulation and retention of drug. In this study, the effect of the calmodulin inhibitor trifluoperazine on the cellular accumulation, retention, and cytotoxic effects of ADR in ADR-sensitive (P388/S) and ADR-resistant (...

2017
Fan Wang Jeremy T-H. Chang Zhenyu Zhang Gladys Morrison Aritro Nath Steven Bhutra Rong Stephanie Huang

Ovarian cancer accounts for the highest mortality among gynecologic cancers, mainly due to intrinsic or acquired chemoresistance. While mechanistic-based methods have been used to identify compounds that can overcome chemoresistance, an effective comprehensive drug screening has yet to be developed. We applied a transcriptome based drug sensitivity prediction method, to the Cancer Genome Atlas ...

2016
Winyoo Chowanadisai Shanta M. Messerli Daniel H. Miller Jamie E. Medina Joshua W. Hamilton Mark A. Messerli Alexander S. Brodsky

The majority of ovarian tumors eventually recur in a drug resistant form. Using cisplatin sensitive and resistant cell lines assembled into 3D spheroids we profiled gene expression and identified candidate mechanisms and biological pathways associated with cisplatin resistance. OVCAR-8 human ovarian carcinoma cells were exposed to sub-lethal concentrations of cisplatin to create a matched cispl...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2007
Yujian Zhang Laiman Xiang Raffit Hassan Ira Pastan

Recombinant immunotoxins are chimeric proteins composed of the Fv portion of a tumor-specific antibody fused to a toxin. SS1P (CAT-5001) is an immunotoxin composed of an antimesothelin Fv fused to a 38-kDa portion of Pseudomonas exotoxin A. Immunotoxins have been shown to be active in lymphomas and leukemias, but are much less active against solid tumors. We recently reported that Taxol and oth...

Journal: :Cancer research 1987
J Meador P Sweet M Stupecky M Wetzel S Murray S Gupta L Slater

Cyclosporin A abrogates pleiotropic drug resistance in certain experimental tumors. Its impact on drug-sensitive tumors has not been investigated. Our studies show that in drug-sensitive Ehrlich ascites carcinoma and hepatoma 129 cyclosporin A enhances daunorubicin inhibition of DNA synthesis in vitro and prolongs survival of host mice in vivo. Of particular interest is that cyclosporin A conve...

2006
Ram Ganapathi Dale Grabowski

Resistance to the cytotoxic effects of daunomycin and Adria mycin (ADR) in sublines of Ehrlich ascites and P388 mouse tumors has been demonstrated to be due to reduced cellular accumulation and retention of drug. In this study, the effect of the calmodulin inhibitor trifluoperazine on the cellular accumula tion, retention, and cytotoxic effects of ADR in ADR-sensitive (P388/S) and ADR-resistant...

Journal: :Cancer research 2000
Y Ogiso A Tomida S Lei S Omura T Tsuruo

Physiological cell conditions, such as glucose deprivation and hypoxia, play a role in developing drug resistance in solid tumors. These tumor-specific conditions cause decreased expression of DNA topoisomerase IIalpha (topo IIalpha), rendering cells resistant to topo II-targeted drugs, such as etoposide and doxorubicin. We show here that inhibition of proteasome attenuated drug resistance by i...

Journal: :The Journal of pharmacology and experimental therapeutics 2008
Fei Shen Shaoyou Chu Aimee K Bence Barbara Bailey Xinjian Xue Priscilla A Erickson Marshall H Montrose William T Beck Leonard C Erickson

P-glycoprotein (Pgp), a membrane transporter encoded by the MDR1 gene in human cells, mediates drug efflux from cells, and it plays a major role in causing multidrug resistance (MDR). Confocal microscopy was used to study in vitro and in vivo drug accumulation, net uptake and efflux, and MDR modulation by P-glycoprotein inhibitors in MDR1-transduced human MDA-MB-435mdr (MDR) cancer cells. The M...

2014
Kimberly S Corbin Hedy L Kindler Stanley L Liauw

Gastrointestinal stromal tumors (GISTs) are rare mesenchymal tumors arising in the gastrointestinal tract. Over the last decade, the management and prognosis of GISTs has changed dramatically with molecular characterization of the c-kit mutation and the adoption of targeted systemic therapy. Currently, the standard of care for resectable tumors is surgery, followed by adjuvant imatinib for tumo...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید